PTPN11 mutations are frequently associated with acute myelomonocytic/monocytic leukemia subtypes, and PTPN11 is associated with lower rates of complete remission and shorter overall survival (Alfayez et al., 2021). The gene discussed is PTPN11; the disease is monocytic leukemia.